Innovative solutions to
keep your project on course

Comparator PK/PD Analysis

How will your drug stand out in the marketplace?

Throughout the drug development process (pre-market), and as you introduce your new drug to the marketplace (post-approval), a comparator PK/PD Analysis can help guide your next steps and frame your messaging. With modeling, simulation and a meta-analysis of clinical data, our team of industry-veteran pharmacometricians can conduct a comparator PK/PD analysis and evaluate a drug’s efficacy, safety, toxicity, and more.

Pre-Market Guidance

Robust sales of approved pharmaceuticals start with intelligent pre-market drug development strategies. PK/PD analyses can help position your drug to:

  • Optimize dosing
  • Reduce time to market
  • Strengthen market position versus competitors
  • Enhance uptake by the medical community
  • and more

Post-Approval Guidance

By the time a drug gets to market, the pressure is on to sell. Imagine being able to hand a physician an evidence-based analysis showing how your drug is better for their patients than your competitor’s drug? Comparator PK/PD Analyses can provide the information you need to be able to do just that.

Investigator-Initiated Studies

Data for your drug is being generated and published from Investigator-Initiated Studies. Our team works with Investigators to ensure that:

  • Studies are designed appropriately to produce robust results
  • Studies are conducted according to all FDA regulations

Questions a Comparator PK/PD Analysis Can Answer

  • What is the optimal dose for patients?
  • How does your drug’s efficacy compare with competitors?
  • How can your drug be used with other medications?
  • How should you position your drug in the marketplace?
  • How does your drug’s safety compare with competitors?

Our team of industry-veteran pharmacometricians can conduct a comparator PK/PD analysis with modeling, simulation and a meta-analysis of your program’s clinical data. Conducting a comparator PK/PD analysis can help guide your next steps in drug development and help frame your messaging for post-approval marketing.

Contact us to learn how a comparator PK/PD analysis can help your program.

Contact Us

Explore Our Blog

Comparing the FDA’s Pharmacogenomic Biomarkers and Pharmacogenetic Associations Tables

Pharmacogenomics (PGx), which considers the relationship between an individual’s genetics and their response to medications (i.e., drug-gene interactions), is expanding…

Read More

PBPK Modeling & Simulation in Drug Development

What is PBPK Modeling & Simulation? Physiological based pharmacokinetic modeling and simulation (PBPK) is a computer modeling approach that incorporates…

Read More

How to Avoid Clinical Trials Using Modeling & Simulation

With modeling and simulation, data can be leveraged to provide important insights on product safety and effectiveness. Modeling and simulation…

Read More